tiprankstipranks
Trending News
More News >
Wai Yuen Tong Medicine Holdings Limited (HK:0897)
:0897
Hong Kong Market
Advertisement

Wai Yuen Tong Medicine Holdings Limited (0897) Financial Statements

Compare
2 Followers

Wai Yuen Tong Medicine Holdings Limited Financial Overview

Wai Yuen Tong Medicine Holdings Limited's market cap is currently HK$427.54M. The company's EPS TTM is HK$-0.015; its P/E ratio is 56.35; and it has a dividend yield of 8.45%. Wai Yuen Tong Medicine Holdings Limited is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueHK$ 745.30MHK$ 783.88MHK$ 1.29BHK$ 1.39BHK$ 1.11B
Gross ProfitHK$ 376.45MHK$ 394.81MHK$ 609.54MHK$ 574.15MHK$ 448.26M
Operating IncomeHK$ -31.70MHK$ 40.88MHK$ 51.55MHK$ 56.16MHK$ -23.32M
EBITDAHK$ 122.72MHK$ 138.31MHK$ 115.88MHK$ 154.62MHK$ -107.44M
Net IncomeHK$ 7.10MHK$ -15.36MHK$ -20.52MHK$ -108.91MHK$ -376.00M
Balance Sheet
Cash & Short-Term InvestmentsHK$ 146.55MHK$ 196.78MHK$ 625.01MHK$ 683.74MHK$ 688.93M
Total AssetsHK$ 1.74BHK$ 2.10BHK$ 7.01BHK$ 7.60BHK$ 7.96B
Total DebtHK$ 435.41MHK$ 560.07MHK$ 1.76BHK$ 1.80BHK$ 1.77B
Net DebtHK$ 303.09MHK$ 405.10MHK$ 1.19BHK$ 1.26BHK$ 1.24B
Total LiabilitiesHK$ 555.68MHK$ 709.65MHK$ 3.33BHK$ 3.64BHK$ 4.01B
Stockholders' EquityHK$ 1.18BHK$ 1.39BHK$ 2.35BHK$ 2.52BHK$ 2.57B
Cash Flow
Free Cash FlowHK$ 75.16MHK$ 157.04MHK$ 58.13MHK$ 90.14MHK$ 298.99M
Operating Cash FlowHK$ 102.32MHK$ 191.69MHK$ 91.58MHK$ 116.18MHK$ 358.49M
Investing Cash FlowHK$ 280.89MHK$ -84.62MHK$ 15.06MHK$ -15.91MHK$ -81.78M
Financing Cash FlowHK$ -405.69MHK$ -469.97MHK$ -67.25MHK$ -115.27MHK$ -266.48M
Currency in HKD

Wai Yuen Tong Medicine Holdings Limited Earnings and Revenue History

Wai Yuen Tong Medicine Holdings Limited Debt to Assets

Wai Yuen Tong Medicine Holdings Limited Cash Flow

Wai Yuen Tong Medicine Holdings Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis